Keyphrases
Core Outcome Set
100%
Randomized Controlled Trial
82%
Clinical Trials
35%
Sectional Analysis
25%
Urology
17%
Harms Reporting
15%
Type 1 Diabetes Mellitus (T1DM)
12%
Inflammatory Bowel Disease
11%
Perioperative Pain
11%
Type I Diabetes
11%
Drug Companies
11%
Cost-plus
11%
Ketorolac
11%
Cuban
11%
Chronic Kidney Disease
11%
Preterm Birth
11%
Clinical Trial Registry
9%
Medicare
9%
Data Extraction
9%
Inclusion Criteria
8%
Medicare Part D
6%
Reporting Guidelines
6%
Immune Thrombocytopenia
6%
Adverse Events
6%
Cost-savings Potential
5%
Preterm Birth Prevention
5%
Communication Disorders
5%
Macular Degeneration
5%
Most Cited Publications
5%
Stroke Trials
5%
Scientific Community
5%
Gender Representation
5%
Drosophila Species
5%
Top 100
5%
Mohs Micrographic Surgery
5%
Ethics Review Committees
5%
Bibliometric Analysis
5%
Parkinson's Disease
5%
Immune Thrombocytopenic Purpura
5%
Ovarian Cancer
5%
Lung Cancer
5%
Drosophilidae
5%
Diabetes Medications
5%
Seizure
5%
Knee Osteoarthritis
5%
Hip Osteoarthritis
5%
Trial Characteristics
5%
Medicine and Dentistry
Randomized Controlled Trial
65%
Clinical Trial
47%
Cross Sectional Study
36%
Systematic Review
19%
Urology
17%
Ketorolac
11%
Idiopathic Thrombocytopenic Purpura
11%
Lung Cancer
11%
Chronic Kidney Disease
11%
Clinician
8%
Patient Care
8%
Quality of Life
7%
Adverse Event
6%
Inflammatory Bowel Disease
5%
Mohs Surgery
5%
Insulin Dependent Diabetes Mellitus
5%
Apoplexy
5%
Thrombocytopenic Purpura
5%
Ovarian Cancer
5%
Parkinson's Disease
5%
Inflammatory Bowel Disease
5%
Opioid Abuse
5%
Hip
5%
Knee
5%
Intoxication
5%
Marginalised Population
5%
Osteoarthritis
5%
Health Care
5%